The COVID Boom: CBER Receives More INDs in One Quarter Than The Previous 30 Combined

Hand grabbing rising line
CBER continued to see INDs for cell and gene therapies, in addition to COVID-19 countermeasures, in recent months. • Source: Alamy

More from United States

More from North America